Promoter holding
64.27%
PP
Pulse Pharmaceuticals Private Limited - Due diligence report
A 360° intelligence report on Pulse Pharmacy: trust score, financial health, credit view, compliance, directors, growth and distress signals…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Pulse Pharmacy — 360° Intelligence Report
Generated from MCA filings & public records51/100
Trust Score
Moderate
Pulse Pharmacy is assessed as Moderate with a Trust Score of 51/100. Pulse Pharmacy is an active private limited indian non-government company incorporated in 1997, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and high financial risk profile.
Report generated on 16 Jul 2026 from the latest processed filings. Pulse Pharmaceuticals Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
51/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
26/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
30/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
25/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
65/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
50/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 25/100 Caution Indicated
- Liabilities ≈ 38% EBITDA - stretched.
- Open charges exceed net worth - secured lenders rank ahead.
- Elevated gearing (D/E 1.42).
- Externally credit-rated (A3).
Charges position: 5 open (80.28 cr) · 9 satisfied (44.05 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Others | 9 | 48.0 cr |
| Punjab National Bank | 1 | 48.0 cr |
| Axis Bank | 1 | 48.0 cr |
| Hdfc Bank Limited | 2 | 48.0 cr |
| Axis Bank Limited | 1 | 48.0 cr |
Compliance Score: 26/100 Caution Indicated
- Company status is Active as per MCA.
- Balance sheet slightly behind (Mar 2024).
- Flagged by authority: EPFO.
- Litigation present in 2 court forum(s).
- 1 auditor resignation(s) filed - latest: UMESH & KRSHNA on 2024-05-21.
- Delayed payments to MSME suppliers disclosed (518 disclosure(s)).
- 14 active GST registration(s).
Legal cases on record (2)
05
Director Intelligence
Stability score: 90/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| RAMBHAU DEVRAJ | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SURESH BABU KATRAGADDA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| DIVYA KATRAGADDA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| RAMESH KUMAR SURAMPUDI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SRIKANTH CHOUDARY MYNENI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| VENKAT RAM BABU KATRAGADDA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| VENKATESWARLU NELABHOTLA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 7 directors on the board.
- No disqualified or deactivated DINs.
- 1 director exit(s) in the last 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2024)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2024 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 0 transfer(s)
Promoters hold a majority stake - exact percentages are part of the full report.
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 65 · Distress 50
Growth signals & trust indicators
Steady revenue growth: +2.1x over 4 year(s).
Asset base grew 24% - capacity expansion.
Operating for 29+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Losses deepening year-on-year.
Outside liabilities up 0.86 in a year.
Compliance score is weak (26/100).
5 open charge(s) registered - assets are encumbered.
1 auditor resignation(s) on record - review the stated reasons.
MSME payment delays disclosed - latest outstanding 3.26 cr.
2 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence41/100
Caution indicated
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 3 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment27/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 5 open charge(s) of 80.28 cr already registered.
- Compliance gaps should be priced into terms.
Investor view49/100
Mixed indicators
Growth quality and scalability through an investor lens.
- 2 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events08 Nov 2025
Charge satisfied
Hdfc Bank Limited
08 Oct 2025
Charge satisfied
Others
Charge satisfied
Axis Bank Limited
29 May 2025
Charge satisfied
Others
20 May 2025
Charge satisfied
Others
28 Sep 2024
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
30 Nov 2023
Charge created
Others - 5.00 cr
28 Sep 2023
Director ceased
VENKATESWARLU NELABHOTLA
31 Jul 2023
Charge created
Others - 1.49 cr
28 May 2023
Charge created
Others - 1.40 cr
28 Mar 2023
Charge created
Others - 7.00 cr
10 Nov 2022
Director appointed
VENKATESWARLU NELABHOTLA (Director)
24 Feb 2022
Securities allotted
300 Debentures - 30.00 cr raised
18 Feb 2022
Charge created
Others - 30.00 cr
10
Key Observations
Auto-generated from the data aboveRevenue grew 61% over the last 4 financial year(s).
Net profit margin moved from 38% to 1.42.
Debt-to-equity stands at 2.1x - leverage worth monitoring.
Net worth is positive.
7 active director(s) / partner(s); board looks stable and experienced.
14 active GST registration(s) indicate ongoing business operations.
Carries an external credit rating of A3 from Crisil.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a majority stake as per the FY 2024 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
1 overseas direct investment(s) (ODI) on record - international footprint.
| Company | CIN | Location |
|---|---|---|
| Baroda Agro Chemicals Limited | U24219GJ1996PLC028630 | Raluka Halol Panchmahals, Gujarat, India |
| Ichor Biologics Private Limited | U24239TG2021PTC149331 | Medchal Malkajgiri, Telangana, India |
| Centurion Remedies Private Limited | U24231GJ2003PTC042254 | Baroda, Gujarat, India |
| Kekule Pharma Limited | U24231TG1984PLC005145 | Hyderabad, Telangana, India |
| Inject Care Parenterals Private Limited | U24231GJ2002PTC041048 | Vapi, Gujarat, India |
| Wardex Pharmaceuticals Private Limited | U51397TN1946PTC005759 | Madras-29, Tamil Nadu, India |
| Amn Life | U24230MH2003PTC140663 | Mumbai, Maharashtra, India |
| Ideal Detonators Private Limited | U24292TG1989PTC010513 | Secunderabad, Telangana, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Pulse Pharmacy before audits and certifications: compliance score 26/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Pulse Pharmacy: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Enhanced diligence advised. Credit risk score 25/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Mixed indicators. Growth score 65/100, margin trends, ownership structure and peer set for Pulse Pharmacy - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Caution indicated. Trust score 51/100, distress signals and MSME payment-delay disclosures - know whether Pulse Pharmacy pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Pulse Pharmacy - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Pulse Pharmacy an active company?
Pulse Pharmacy has MCA status “Active” with a compliance score of 26/100 (Caution Indicated).
Is Pulse Pharmacy financially healthy?
Pulse Pharmacy has a Financial Health Score of 30/100 (Caution Indicated) based on its filed financial statements.
Should I do business with Pulse Pharmacy?
Its overall Trust Score is 51/100 (Moderate). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Pulse Pharmacy?
Promoters hold a majority stake - exact percentages are in the full report. 7 active director(s) are on record.
Does Pulse Pharmacy have loans or charges against its assets?
5 open charge(s) are registered against its assets, and 9 earlier charge(s) stand satisfied.
Is Pulse Pharmacy up to date with its ROC filings?
Balance sheet slightly behind (Mar 2024). Overall compliance score: 26/100 (Caution Indicated).
Is it risky to lend to Pulse Pharmacy?
Its Credit Risk Score is 25/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
